Global Patient-Centric Healthcare Application Market Report 2022:

Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) — The “Patient-Centric Healthcare Application Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027” report has been added to from offer.

The global patient-centric healthcare application market size reached US$8.62 billion in 2021. Looking ahead, the publisher expects the market to reach US$30.89 billion by 2027, growing at a CAGR of 23.7% in 2021-2027.

A patient-centric healthcare application (app) offers health-related services conveniently from a device, such as a smartphone and tablet. It is used by patients to monitor many aspects of their health, including weight, calorie count, blood sugar readings, dehydration levels, and physical activity. It helps manage chronic diseases like diabetes and hypertension and facilitates electronic data interchange (EDI) with clinicians. Currently, there is a significant increase in the use of telehealth/telemedicine due to the coronavirus disease (COVID-19) outbreak. As a result, the demand for patient-centric healthcare applications is increasing worldwide.

Patient-Centric Healthcare Application Market Trends:

These days, mobile app developers are collaborating with healthcare experts to deliver patient-centric healthcare apps that can work without an internet connection to support uninterrupted access. This, in conjunction with the growing reliance on smartphones and other devices for disease surveillance, represents one of the major factors driving the market. Additionally, patient-centric healthcare apps help with smoking cessation and track nutritional intake and vaccinations.

They also allow practitioners to ensure that treatments recognize a patient’s needs and preferences. As a result, these apps are increasingly being used by people with cancer to log medications, track treatment progress, monitor side effects, and schedule follow-up appointments. Additionally, advances in information technology (IT) have introduced new design approaches that include healthcare delivery and patient education.

This, coupled with the increasing adoption of wearable devices, which help monitor heart rate, tremor, posture control, and sleep patterns, provides lucrative growth opportunities for market players. Other factors such as increasing geriatric population and increasing health awareness among individuals are driving the market.

Key Market Segmentation:

The publisher provides an analysis of the main trends in each sub-segment of the global patient-centric healthcare applications market, as well as forecasts at the global, regional and country levels from 2022 to 2027. Our report has classified the market according to technology, operating system, application and end user.

Breakdown by technology:

  • Phone based applications
  • Web apps
  • Patient-Centric Wearable Applications

Breakdown by operating system:

Breakdown by application:

  • wellness management
  • Management of diseases and treatments

Breakdown by end user:

Breakdown by region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation

5 Global Patient-Centric Healthcare Application Market

6 Market Breakdown by Technology

7 Market Breakdown by Operating System

8 Market Breakdown by Application

9 Market Breakdown by End User

10 Market Breakdown by Region

11 SWOT Analysis

12 Value chain analysis

13 Analysis of the five forces of carriers

14 Price Analysis

15 Competitive landscape

Companies cited

  • Allscripts Healthcare Solutions Inc.
  • Athenasanté inc.
  • Bayer Aktiengesellschaft
  • Boston Scientific Society
  • Hill-Rom Services Inc. (Baxter International Inc.)
  • iPatientCare LLC
  • Koninklijke Philips NV
  • Merck & Co. Inc.
  • Mobile Smith Inc.
  • Pfizer Inc.
  • Siemens Healthineers AG (Siemens AG).

For more information on this report, visit


Comments are closed.